BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 18502503)

  • 1. Allogeneic bone marrow transplantation after L-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia.
    Yamada Y; Ito K; Watanabe Y; Nosaka K; Horikawa K; Hidaka M; Kawano F; Sasaki Y; Mitsuya H; Asou N
    Leuk Res; 2008 Dec; 32(12):1944-6. PubMed ID: 18502503
    [No Abstract]   [Full Text] [Related]  

  • 2. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
    Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH
    Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic panniculitis caused by L-asparaginase induced acute pancreatitis in a child with acute lymphoblastic leukemia.
    Chiewchengchol D; Wananukul S; Noppakun N
    Pediatr Dermatol; 2009; 26(1):47-9. PubMed ID: 19250405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
    Wu SF; Chen AC; Peng CT; Wu KH
    Pediatr Blood Cancer; 2008 Dec; 51(6):824-5. PubMed ID: 18726919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase].
    Wlazłowski M; Celińska W; Maciejka-Kapuścińska L; Płoszyńska A; Idczak E
    Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):296-7. PubMed ID: 7808958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute pancreatitis secondary to L-asparaginase (a case report)].
    Tazi I; Rachid M; Quessar A; Harif M; Benchekroun S
    East Mediterr Health J; 2009; 15(2):475-9. PubMed ID: 19554997
    [No Abstract]   [Full Text] [Related]  

  • 7. L-asparaginase induced intracranial haemorrhage in acute lymphoblastic leukemia.
    Lim HL; Teo CP; Wong K; Kueh YK
    Singapore Med J; 1998 Feb; 39(2):76-8. PubMed ID: 9652181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retherapy using L-asparaginase with octreotide in a patient recovering from L-asparaginase-induced pancreatitis.
    Suzuki M; Takata O; Sakaguchi S; Fujimura J; Saito M; Shimizu T
    Exp Hematol; 2008 Mar; 36(3):253-4. PubMed ID: 18279714
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic.
    Morimoto A; Imamura T; Ishii R; Nakabayashi Y; Nakatani T; Sakagami J; Yamagami T
    Cancer; 2008 Sep; 113(6):1362-9. PubMed ID: 18661511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient hyperthyroidism following L-asparaginase therapy for acute lymphoblastic leukemia.
    Fadilah SA; Faridah I; Cheong SK
    Med J Malaysia; 2000 Dec; 55(4):513-5. PubMed ID: 11221167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
    Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S
    Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic pseudocyst complicating treatment of acute lymphoblastic leukemia.
    Tomar S; Bakhshi S; Kabra SK; Arya LS
    Indian Pediatr; 2003 Jul; 40(7):670-2. PubMed ID: 12881625
    [No Abstract]   [Full Text] [Related]  

  • 13. L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia.
    Sahu S; Saika S; Pai SK; Advani SH
    Pediatr Hematol Oncol; 1998; 15(6):533-8. PubMed ID: 9842647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
    Beinart G; Damon L
    Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of ALL complicated with acute pancreatitis and pancreatic pseudocyst caused by L-asparaginase ].
    Yasui I; Shimokawa T; Kasai M; Yamada H; Watanabe E; Takeyama H; Satake T
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):149-52. PubMed ID: 8422180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia.
    Earl M
    Clin Adv Hematol Oncol; 2009 Sep; 7(9):600-6. PubMed ID: 20020672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in allogeneic and autologous BMT for acute lymphoblastic leukaemia (ALL).
    Barrett J
    Bone Marrow Transplant; 1991; 7 Suppl 2():59-61. PubMed ID: 1878722
    [No Abstract]   [Full Text] [Related]  

  • 18. Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol.
    Raja RA; Schmiegelow K; Albertsen BK; Prunsild K; Zeller B; Vaitkeviciene G; Abrahamsson J; Heyman M; Taskinen M; Harila-Saari A; Kanerva J; Frandsen TL;
    Br J Haematol; 2014 Apr; 165(1):126-33. PubMed ID: 24428625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful use of octreotide as a chemoprotectant for prevention of PEG-asparaginase-induced pancreatitis.
    Buie LW; Moore J; van Deventer H
    Pharmacotherapy; 2014 Aug; 34(8):e149-51. PubMed ID: 25112526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does octreotide prevent L-asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia?
    Tokimasa S; Yamato K
    Br J Haematol; 2012 May; 157(3):381-2. PubMed ID: 22145577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.